Alfa Chemistry has expanded its recombinant protein portfolio, providing researchers with a broader selection of proteins for drug discovery, translational research, cell-based assays, and biologics development. The portfolio includes recombinant proteins covering a broad range of biological targets to support research and therapeutic applications.
Building on its experience in supplying research reagents for drug discovery and life science research, Alfa Chemistry continues to strengthen its recombinant protein offering with products designed to support target identification, functional studies, antibody discovery, biomarker research, and therapeutic evaluation.
Alfa Chemistry’s recombinant protein portfolio includes proteins produced using bacterial, yeast, insect, and mammalian expression systems, allowing researchers to select proteins based on expression systems, post-translational modification requirements, and downstream applications. These expression platforms provide flexibility for projects requiring different levels of protein complexity and biological activity.
The portfolio includes recombinant proteins for various research applications, including CAR-T therapy target proteins, immune checkpoint proteins, cytokines and growth factors, CD proteins, receptor proteins, viral proteins, complement proteins, enzymes, and MHC proteins. Together, these products support research across immunology, immuno-oncology, infectious diseases, neuroscience, metabolism, regenerative medicine, and other areas of biomedical research.
“Researchers are increasingly working across multiple expression systems and therapeutic areas,” said a spokesperson for Alfa Chemistry. “Expanding our recombinant protein portfolio enables us to better support workflows ranging from target validation to cell-based assay development with a broader selection of research proteins.”
More information about Alfa Chemistry’s recombinant protein portfolio is available on the Alfa Chemistry website.
About Alfa Chemistry
Alfa Chemistry is a global supplier of research chemicals, life science reagents, advanced materials, and analytical solutions. The company provides a broad portfolio of products and scientific services to support universities, research institutes, biotechnology companies, pharmaceutical organizations, and industrial laboratories worldwide.
CAR-T Therapy Target Proteins
